Who owns PHARVARIS N V?
- Ticker: PHVS
- CUSIP Number: n69605108
Tip: Access positions for across all investors
Analyze quarterly positions in Pharvaris N V with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pharvaris N V stock
Who bought or sold PHARVARIS N V this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| General Atlantic | 7.5M | $140M | 0% | Sep 2024 |
|
| Foresite Capital Management IV | 4.4M | $81M | 2% | Sep 2024 |
|
| venBio Partners | 4.3M | $79M | 0% | Sep 2024 |
|
| Viking Global Investors | 3.7M | $68M | 0% | Sep 2024 |
|
| VR Adviser | 3.4M | $63M | 0% | Sep 2024 |
|
| Bain Capital Life Sciences Investors | 3.3M | $62M | 0% | Jun 2024 |
|
| Deerfield Management Company | 2.0M | $38M | 45% | Sep 2024 |
|
| Commodore Capital | 1.9M | $35M | 6% | Sep 2024 |
|
| Novo A/S | 1.7M | $32M | 0% | Sep 2024 |
|
| Cormorant Asset Management | 1.5M | $28M | -14% | Jun 2024 |
|
| EcoR1 Capital | 900k | $17M | 0% | Jun 2024 |
|
| 5AM Venture Management | 798k | $15M | 0% | Sep 2024 |
|
| Rock Springs Capital Management | 757k | $14M | 1% | Jun 2024 |
|
| Octagon Capital Advisors | 621k | $12M | 100% | Sep 2024 |
|
| Sofinnova Ventures | 600k | $11M | 0% | Sep 2024 |
|
| Sphera Funds Management | 403k | $7.6M | 3% | Jun 2024 |
|
| Soleus Capital Management | 399k | $7.5M | -1% | Jun 2024 |
|
| T. Rowe Price Associates | 326k | $6.0M | -44% | Sep 2024 |
|
| Patient Square Capital | 242k | $4.5M | 100% | Sep 2024 |
|
| BlackRock | 195k | $3.6M | 100% | Sep 2024 |
|
| Goldman Sachs Group | 62k | $1.2M | 98% | Jun 2024 |
|
| Marshall Wace | 59k | $1.1M | 15% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 55k | $1.0M | 0% | Jun 2024 |
|
| ALPS Advisors | 42k | $784k | 100% | Sep 2024 |
|
| Geode Capital Management | 37k | $685k | 18% | Sep 2024 |
|
| TD Asset Management | 36k | $671k | -58% | Sep 2024 |
|
| HealthInvest Partners AB | 34k | $636k | 100% | Sep 2024 |
|
| Jane Street | 28k | $526k | 100% | Sep 2024 |
|
| Swiss National Bank | 26k | $486k | 100% | Sep 2024 |
|
| Morgan Stanley | 23k | $438k | -20% | Jun 2024 |
|
| Deutsche Bank Aktiengesellschaft | 16k | $298k | 100% | Sep 2024 |
|
| Crestline Management | 16k | $293k | 100% | Sep 2024 |
|
| Northern Trust | 16k | $292k | 100% | Sep 2024 |
|
| California State Teachers Retirement System | 13k | $240k | 100% | Sep 2024 |
|
| Barclays | 5.7k | $106k | 100% | Sep 2024 |
|
| Ohio Pers | 3.1k | $57k | 100% | Sep 2024 |
|
| BlackRock | 2.3k | $43k | 0% | Jun 2024 |
|
| Wells Fargo & Company | 800.00 | $15k | 14% | Sep 2024 |
|
| Jpmorgan Chase & Co | 253.00 | $4.7k | 100% | Sep 2024 |
|
| Amundi | 84.00 | $1.5k | 100% | Sep 2024 |
|
| Bank of America Corporation | 15.00 | $277.999500 | -100% | Sep 2024 |
|
Who sold out of Pharvaris N V?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 39k | $732k |
| Qube Research & Technologies | Mar 2024 | 30k | $697k |
| Y-Intercept | Jun 2024 | 16k | $299k |
| Citadel Advisors | Jun 2024 | 15k | $272k |